2023 AANEM Annual Meeting

JW Marriott Desert Ridge, Phoenix, AZ  
Wednesday, November 01, 2023 - Saturday, November 04, 2023   iCalendar Pacific Standard Time

Registration is located in the Grand Canyon Foyer

 

The 2023 annual meeting will focus on improving patient care, medical knowledge, interpersonal communication, professionalism, and systems-based practices in the following areas:  updates in NM and MSK disorders; status of inherited muscle diseases; genomics and emerging gene therapies;  new technologies and treatments; autoimmune disorders;  neuropathies, antibody testing, US, EDX, and biopsy skills.

After attending this activity, attendees will:

• Enhance their ability to obtain a comprehensive patient history and examination; improve their ability to develop a differential diagnosis and direct appropriate diagnostic work-ups; assess rehabilitation potential for patients with NM and MSK disease; treat patients with pain, utilize EMG to precisely assess the severity of nerve injuries, recognize the association of immunization with new onset of NM diseases and how COVID impacts patient care, and recognize how assessment techniques can improve the lives of patients. (Patient care)

• Develop technical skills necessary to perform neurologic, EDX, and rehabilitative procedures; identify and describe important EDX, biopsy, genetic, and US findings; develop awareness of treatments, therapies, and side effects, and discuss the latest literature on NM disorders. (Medical knowledge, Practice-based learning)

• Improve ability to communicate with and educate patients, families, and members of the healthcare team; articulate a confident clinical approach to common questions faced as an inpatient consultant; demonstrate professionalism in clinical, research, and academic practice. (Interpersonal communication skills, Professionalism)

• Develop strategies for working in a multidisciplinary session, awareness of emerging treatments and therapies; identify and access supportive healthcare services and mechanisms that improve patient care and patient quality of life. (Systems-based practice)

Speakers

Dr. Craig M. McDonald

Sacramento, CA
United States

Dr. McDonald is an internationally recognized expert in the clinical management and rehabilitation of neuromuscular diseases including muscular dystrophies and the development of novel outcome measures for clinical trials. He also is widely known for his expertise in the management and assessment of children and young adults with Duchenne muscular dystrophy. Dr. McDonald currently serves as Director and Principal Investigator of the UC Davis NINDS-funded grant withinin the NeuroNEXT Neurosciences Clinical Trials National Consortium. He is also Director of the UC Davis NIDILRR-funded Rehabilitation Research and Training Center in Neuromuscular Diseases. He also serves as Chair of PM&R and is Professor of Pediatrics and PM&R at the University of California Davis in Sacramento. Dr. McDonald’s research has focused on novel clinical endpoint development in neuromuscular diseases, and he has conducted natural history studies in muscular dystrophies using novel outcomes measures developed for clinical trials. He leads the international CINRG Duchenne Natural History Study which has made seminal contributions to the elucidation of the natural history of Duchenne muscular dystrophy (DMD), validation of the clinical endpoints now used in clinical trials of DMD throughout the world, the development of novel endpoints to assess more severely affected patients with DMD who are non-ambulatory, identification of genetic modifiers which affect DMD disease progression, and application of proteomics to identify novel candidate biomarkers for Duchenne clinical trials. Most importantly his work has contributed to the development of precision-based therapeutics for DMD and the first two approved therapies targeting mechanisms involved in dystrophin restoration. He has been a recipient of over $25 million in federal grant and industry support over the past 15 years. He holds subspecialty certifications in pediatric rehabilitation medicine and neuromuscular medicine.